Browse > Article

Analysis of In Vivo Interaction of HCV NS3 Protein and Specific RNA Aptamer with Yeast Three-Hybrid System  

HWANG BYOUNGHOON (Department of Molecular Biology, Institute of Nanosensor and Biotechnology, Dankook University)
LEE SEONG-WOOK (Department of Molecular Biology, Institute of Nanosensor and Biotechnology, Dankook University)
Publication Information
Journal of Microbiology and Biotechnology / v.15, no.3, 2005 , pp. 660-664 More about this Journal
Abstract
We have previously isolated specific RNA aptamers with high affinity against the helicase domain of hepatitis C virus (HCV) nonstructural protein 3 (NS3). The RNA aptamers competitively and efficiently inhibited the helicase activity, partially impeding HCV replicon replication in human hepatocarcinoma cells. In this study, the RNA aptamers were tested for binding to the HCV NS3 proteins in eukaryotic cells, using a yeast three-hybrid system. The aptamers were then recognized by the HCV NS3 proteins when expressed in the cells, while the antisense sequences of the aptamers were not. These results suggest that the in vitro selected RNA aptamers can also specifically bind to the target proteins in vivo. Consequently, they could be potentially utilized as anti-HCV lead compounds.
Keywords
HCV; NS3; RNA aptamer; yeast three-hybrid system;
Citations & Related Records

Times Cited By Web Of Science : 5  (Related Records In Web of Science)
연도 인용수 순위
  • Reference
1 Ellington, A. D. and J. W. Szostak. 1990. In vitro selection of RNA molecules that bind specific ligands. Nature 346: 818-822   DOI   ScienceOn
2 Fried, M. W., M. L. Shiffman, K. R. Reddy, C. Smith, G. Marinos, F. L. Jr. Goncales, D. Haussinger, M. Diago, G. Carosi, D. Dhumeaux, A. Craxi, A. Lin, J. Hoffman, and J. Yu. 2002. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N. Engl. J. Med. 347: 975-982   DOI   ScienceOn
3 Fukuda, K., D. Vishnuvardhan, S. Sekiya, J. Hwang, N. Kakiuchi, K. Taira, K. Shimotohno, P. K. Kumar, and S. Nishikawa. 2000. Isolation and characterization of RNA aptamers specific for the hepatitis C virus non structural protein 3 protease. Eur. J. Biochem. 267: 3685-3694   DOI   ScienceOn
4 Hwang, B., J. S. Cho, H. J. Yeo, J.-H. Kim, K. M. Chung, K. Han, S. K. Jang, and S.-W. Lee. 2004. Isolation of specific and high-affinity RNA aptamers against NS3 helicase domain of hepatitis C virus. RNA 10: 1277-1290   DOI   ScienceOn
5 Kwong, A. D., J. L. Kim, and C. Lin. 2000. Structure and function of hepatitis C virus NS3 helicase. Curr. Top. Microbiol. Immunol. 242: 171-196
6 Penin, F., J. Dubuisson, F. Rey, D. Moradpour, and J.-M. Pawlotsky. 2004. Structural biology of hepatitis C virus. Hepatology 39: 5-19   DOI   ScienceOn
7 Urvil, P. T., N. Kakiuchi, D.-M. Zhou, K. Shimotohno, P. K. R. Kumar, and S. Nishikawa. 1997. Selection of RNA aptamers that bind specifically to the NS3 protease of hepatitis C virus. Eur. J. Biochem. 248: 130-138   DOI   ScienceOn
8 Jaeger, S., G. Eriani, and F. Martin. 2004. Results and prospects of the yeast three-hybrid system. FEBS Lett. 556: 7-12   DOI   PUBMED   ScienceOn
9 Hugle, T. and A. Cerny. 2003. Current therapy and new molecular approaches to antiviral treatment and prevention of hepatitis C. Rev. Med. Virol. 13: 361-371   DOI   ScienceOn
10 Vo, N. V., J. W. Oh, and M. M. Lai. 2003. Identification of RNA Iigands that bind hepatitis C virus polymerase selectively and inhibit its RNA synthesis from the natural viral RNA templates. Virology 307: 301-316   DOI   ScienceOn
11 Cassiday, L. and L. J. Maher, III. 2001. In vivo recognition of an RNA aptamer by its transcription factor target. Biochemistry 40: 2433-2438   DOI   ScienceOn
12 Lauer, G. M. and B. D. Walker. 2001. Hepatitis C virus infection. N. Engl. J. Med. 345: 41-52   DOI   ScienceOn
13 Biroccio, A., J. Hamm, I. Incitti, R. De Francesco, and L. Tomei. 2002. Selection of RNA aptamers that are specific and high-affinity ligands of the hepatitis C virus RNA-dependent RNA polymerase. J. Virol. 76: 3688-3696   DOI   ScienceOn
14 Baek, C.-H. and K.-S. Kim. 2003. lacz- and aph-based reporter vectors for in vivo expression technology. J. Microbiol. Biotechnol. 13: 872-880
15 SenGupta, D. J., B. Zhang, B. Kraemer, P. Pochart, S. Fields, and M. Wickens. 1996. A three-hybrid system to detect RNA-protein interactions in vivo. Proc. Natl. Acad. Sci. USA 93: 8496-8501
16 Sullenger, B. A. and E. Gilboa. 2002. Emerging clinical applications of RNA. Nature 418: 252-258   DOI   ScienceOn
17 Klausner, R. D., T. A. Rouault, and J. B. Harford. 1993. Regulating the fate of mRNA: The control of cellular iron metabolism. Cell 72: 19-28   DOI   ScienceOn
18 Tuerk, C. and L. Gold. 1990. Systematic evolution ofligands by exponential enrichment: RNA Iigands to bacteriophage T4 DNA polymerase. Science 249: 505-510   DOI   PUBMED
19 Zuker, M. 2003. Mfold web server for nucleic acid folding and hybridization prediction. Nucleic Acids Res. 31: 3406-3415   DOI   PUBMED   ScienceOn
20 Kumar, P. K., K. Machida, P. T. Urvil, N. Kakiuchi, D. Vishnuvardhan, K. Shimotohno, K. Taira, and S. Nishikawa, 1997. Isolation of RNA aptamers specific to the NS3 protein of hepatitis C virus from a pool of completely random RNA. Virology 237: 270-282   DOI   PUBMED   ScienceOn